ALMS
AlumisCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
ALMS vs peer average
60/100
ALMS vs. peer average (C vs. D)
Grade spread
B 2 · C 1 · D 6 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ARQT is the first available peer comparator.
Dermatology-focused commercial comparator identified in the prior baseline; useful for framing a potential psoriasis launch, but its commercial-stage profile is not a clean clinical-risk valuation match.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ALMS
Alumis
ARQT
Arcutis Biotherapeutics
Grade
C
B
Momentum
2
97
Value
41
55
Sentiment
82
54
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs ARQT
ALMS / ARQT
Grade Position
In line
ALMS vs. peer average (C vs. D)
60/100
Momentum
2
ARQTValue
41
ARQTSentiment
82
ALMSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ALMS
ARQT is the first peer returned for this comparison set.